Alastair Garfield
Chief Scientific Officer · 4 filings · Latest: Aug 13, 2026
RHYTHM PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RYTM | Alastair Garfield | Chief Scientific Officer | Aug 13, 2026 | Sale | $117.57 | 7,763 | $912.7K | 2,295 | |
RYTM | ALASTAIR GARFIELD | — | Aug 13, 2026 | Proposed Sale | $117.60 | 7,763 | $912.9K | — | |
RYTM | Alastair Garfield | Chief Scientific Officer | Jul 1, 2026 | Option Exercise | — | 4,445 | — | 12,208 | |
RYTM | Alastair Garfield | Chief Scientific Officer | Feb 1, 2026 | Option Exercise | — | 6,663 | — | 9,789 |